At a glance: AHK-Cu is a lab-made copper peptide used mainly in topical hair and scalp products. Its hair-growth reputation rests on one 2007 lab study on hair follicles in a dish, which has never been replicated. No human trial exists. It is sold as a cosmetic ingredient, not an approved drug, and injecting it is unstudied.
What is AHK-Cu?
AHK-Cu is a copper tripeptide: three amino acids (alanine, histidine and lysine) bound to a copper ion. Some cosmetic suppliers label it "copper tripeptide-3." It is entirely synthetic.
It is a close relative of GHK-Cu (glycine-histidine-lysine plus copper), a copper peptide that occurs naturally in human blood and has been studied since the 1970s. The two differ by a single amino acid, and marketers often blur them together, but research on GHK-Cu does not automatically apply to AHK-Cu.
How is it supposed to work?
AHK-Cu is marketed as a hair-follicle peptide. The proposed effects come almost entirely from one lab study:
- Stimulates dermal papilla cells, the specialized cells at the base of each follicle that control hair growth
- May reduce follicle cell death, which in theory could help follicles stay in the growth phase longer (this effect was not statistically significant)
- Copper delivery, since copper is a cofactor for enzymes involved in collagen and blood vessel formation; this is a general copper-peptide idea, largely drawn from GHK-Cu research
What the research shows so far
| Study | What was tested | Main finding |
|---|---|---|
| Pyo et al., Archives of Pharmacal Research, 2007 | Human hair follicles grown in a dish and cultured dermal papilla cells, at very low concentrations | Follicles grew longer and papilla cells multiplied more; a reduction in cell death was seen but was not statistically significant |
| Human studies of AHK-Cu | None | No clinical trial of any kind has been published |
| GHK-Cu (related peptide) | Cell, animal and small topical human studies | Collagen and wound-healing effects; human data are limited and do not transfer directly to AHK-Cu |
The 2007 study has never been independently replicated. Many claims about AHK-Cu actually cite GHK-Cu research or multi-ingredient products.
Why it gets attention
- Hair loss is common and distressing, and a "peptide" alternative to minoxidil or finasteride has wide appeal
- Cosmetic availability: it appears in serums, sprays and leave-in scalp products
- Halo effect from GHK-Cu, which has a longer research record
- Injectable gray market: some research-peptide sellers offer it for injection, far beyond any evidence
How it is used
AHK-Cu is mainly used topically in hair and scalp products, often alongside GHK-Cu. Unlike GHK-Cu, it is not commonly sold in oral or nasal forms. Injecting AHK-Cu is unstudied: it bypasses the skin barrier and has no human safety data. This page does not provide dosing or application guidance.
What about side effects?
No safety study has been done on AHK-Cu specifically. Topical copper peptides as a class are generally considered low risk, with mild, temporary irritation or skin sensitivity the most commonly reported problem.
- Copper sensitivity: people with a known copper allergy, or copper-metabolism disorders such as Wilson disease, should avoid it.
- Product interactions: combining copper peptides with vitamin C, strong acids, retinoids or benzoyl peroxide in the same step can cause irritation or reduce effectiveness.
- Injection risks are unknown and include infection from non-sterile products.
- Pregnancy and breastfeeding: not studied.
Regulatory status
- Not an FDA-approved drug for hair loss or anything else.
- Sold in the US as a cosmetic ingredient. Cosmetics cannot legally claim to treat or prevent disease, including hair loss, and are not reviewed by the FDA for effectiveness.
- Injectable AHK-Cu sold as a "research peptide" is unregulated and not intended for human use.
- Proven hair-loss treatments include FDA-approved minoxidil and finasteride.
AHK-Cu vs GHK-Cu
| AHK-Cu | GHK-Cu | |
|---|---|---|
| Amino acids | Alanine-histidine-lysine + copper | Glycine-histidine-lysine + copper |
| Origin | Synthetic only | Occurs naturally in human blood; products are lab-made |
| Main marketed use | Hair and scalp | Skin, collagen and wound repair; also scalp |
| Research base | One 2007 lab study | Decades of cell and animal research; limited human topical data |
| Forms sold | Mostly topical | Topical, plus oral, nasal and injectable products |
The bottom line
AHK-Cu is an interesting copper peptide with one encouraging lab study behind it, but that is all the direct evidence there is. It has never been tested on people's hair or scalps in a clinical trial. Topical use appears low risk; injection is unstudied. Anyone dealing with hair loss should see a dermatologist, since effective, approved treatments exist.
Frequently asked questions
What is AHK-Cu?
A three-amino-acid peptide bound to copper, closely related to GHK-Cu. It appears in some hair and skin products.
How is AHK-Cu taken?
Topical.
Is AHK-Cu FDA approved?
Used in cosmetics; not approved as a drug.
That means no regulator has reviewed its safety, effectiveness or manufacturing quality for this use.
What has research shown about AHK-Cu?
- Hair follicle growth in lab studies of human follicles.
- Collagen production in skin cell studies.
What side effects have been reported?
- Topical: skin irritation
Serious or less common risks are listed in the Side Effects section above.
What is still unknown about its safety?
Most of it. AHK-Cu has not been through the trials that establish long-term safety in people, and products sold online are made by unregulated labs. Independent testing of online peptides has repeatedly found contents that do not match the label.
References
- Pyo HK, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research. 2007;30(7):834-839. View source
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987. View source
- Outliyr: AHK-Cu (copper tripeptide) evidence report. View source
- Neurogan Health: AHK-Cu vs GHK-Cu. View source